Difference between revisions of "Pancreas"

Pancreas (view source)

13 bytes removed , 05:38, 4 March 2012

48,830

edits

@@ Line 305: / Line 305: @@
 *IgG4 +ve plasma cells -- IgG4 sclerosing disease.
-To exclude pancreatic carcinoma:<ref name=pmid15725808>{{Cite journal  | last1 = Hornick | first1 = JL. | last2 = Lauwers | first2 = GY. | last3 = Odze | first3 = RD. | title = Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. | journal = Am J Surg Pathol | volume = 29 | issue = 3 | pages = 381-9 | month = Mar | year = 2005 | doi =  | PMID = 15725808 }}</ref> (???)
+Positive in pancreatic carcinoma:<ref name=pmid15725808>{{Cite journal  | last1 = Hornick | first1 = JL. | last2 = Lauwers | first2 = GY. | last3 = Odze | first3 = RD. | title = Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. | journal = Am J Surg Pathol | volume = 29 | issue = 3 | pages = 381-9 | month = Mar | year = 2005 | doi =  | PMID = 15725808 }}</ref>
-*p53 -ve.
+*p53.
-*Mesothelin -ve.
+*Mesothelin.
 =Cystic lesions - overview=